WO2016206180A1 - Bioresorbable bone repair material and application and manufacturing method thereof - Google Patents

Bioresorbable bone repair material and application and manufacturing method thereof Download PDF

Info

Publication number
WO2016206180A1
WO2016206180A1 PCT/CN2015/087598 CN2015087598W WO2016206180A1 WO 2016206180 A1 WO2016206180 A1 WO 2016206180A1 CN 2015087598 W CN2015087598 W CN 2015087598W WO 2016206180 A1 WO2016206180 A1 WO 2016206180A1
Authority
WO
WIPO (PCT)
Prior art keywords
bone
bioabsorbable
calcium phosphate
skull
preparing
Prior art date
Application number
PCT/CN2015/087598
Other languages
French (fr)
Chinese (zh)
Inventor
吴天根
Original Assignee
东莞天天向上医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 东莞天天向上医疗科技有限公司 filed Critical 东莞天天向上医疗科技有限公司
Publication of WO2016206180A1 publication Critical patent/WO2016206180A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00Processes of additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00Products made by additive manufacturing

Definitions

  • the invention belongs to the technical field of artificial prosthesis, and particularly relates to a bioresorbable bone repairing material and a method and a manufacturing method thereof for bone repair.
  • Bone defects caused by various reasons on the bed are very common. It is estimated that in China, traumatic fractures, spinal degenerative diseases, bone tumors, bone tuberculosis and other orthopedic diseases are caused by traffic accidents and production safety accidents each year, causing more than 3 million patients with bone defects or dysfunction. The clinical repair of bone defects has become the consensus of bone surgeons.
  • Clinical requirements for ideal bone repair materials include: (1) Good biocompatibility: in addition to meeting the general requirements of medical materials (such as non-toxic, non-teratogenic, etc.), it is also conducive to seed cell adhesion, proliferation, degradation The product has no toxic and side effects on cells, does not cause inflammatory reaction, and even facilitates cell growth and differentiation; (2) Good biodegradability: the matrix material should be degraded after completion of the scaffold, and the degradation rate should be compatible with the growth rate of the tissue cells.
  • the degradation time should be artificially regulated according to the growth characteristics of the tissue; (3) It has a three-dimensional porous structure: the matrix material can be processed into a three-dimensional structure, which is beneficial to cell adhesion and extracellular matrix deposition, nutrition and oxygen into the human body, and metabolites are discharged. Conducive to vascular and nerve ingrowth; (4) Plasticity and certain mechanical strength: The matrix material has good plasticity and can be pre-made into a certain shape. It has a certain mechanical strength, provides support for new tissue, and maintains a certain time until the new tissue has its own biomechanical properties: (5) Bone guiding activity: bone tissue engineering materials first consider its osteoinductive and osteoconductivity; 6) Easy to disinfect.
  • the traditional bone repair materials mainly include plexiglass, methyl methacrylate bone cement, titanium plate, silicone rubber plate, polymer fiber reinforced material and diacetal acrylate microporous plastic artificial bone. Most of these materials have shortcomings such as poor tissue compatibility, no pressure resistance, no temperature/cold protection, difficulty in shaping, and processing.
  • titanium alloys are non-toxic, have low inflammation and sensitization, have good biocompatibility, low biodegradability and high corrosion resistance. The wider the clinical application. Because the titanium mesh has strong compressive performance and good tissue compatibility, after being implanted into the human body, the fibroblasts can grow into the micropores of the titanium mesh, so that the titanium mesh and the tissue are integrated, and there is a tendency of calcification and ossification. It is an ideal artificial repair material. Although the titanium alloy mesh is better in appearance, it is expensive, difficult to process and non-degradable, and the patient needs to carry it for life. As of now, no material can fully meet the requirements.
  • the autologous skull is the most ideal material for repairing skull defects.
  • the earliest applied autologous skull still occupies an important position in clinical applications.
  • the autologous skull conforms to its own physiology, there is no immune rejection, and there are few common complications of artificial materials such as infection, effusion, and loosening.
  • Ordinary cryopreservation of the autologous skull can survive after implantation, especially for children, and artificial materials cannot increase with the increase of the skull.
  • the autologous skull has the advantages of economy and no need to shape, but its tissue compatibility, whether the bone flap has normal physiological characteristics after ex vivo, and whether the periosteal osteoblasts still survive is not clear.
  • there is bone flap transplantation. Post-absorption and hyperplasia issues deserve further study.
  • Polylactide has good thermoformability, and its degradation rate can be adjusted by adjusting molecular weight and structure to meet different clinical requirements. Therefore, it can basically satisfy the cell growth carrier in the field of bone tissue engineering.
  • the requirements of the material but the polylactic acid material has poor mechanical strength, and the degradation product is slightly acidic.
  • acicular apatite crystal It accounts for about 60% by weight in bone. Its basic unit is acicular apatite crystal. It can be tightly combined with the soft and hard tissues of human body in a short time after being implanted into human body. It is a very good bone repair material. However, the apatite single crystal is fragile, poor strength, poor toughness and difficult to process, which restricts its clinical application.
  • an object of the present invention is to provide a bioabsorbable bone repairing material which can satisfy the conditions for a bone repairing material, has good biocompatibility, sufficient mechanical strength and osteoinductive function. .
  • the second object of the present invention provides the use of the bioabsorbable bone repair material and a method of making the same.
  • the third object of the present invention provides a prosthetic bone.
  • a bioabsorbable bone restorative material comprising a bioabsorbable polyester polymer and calcium phosphate calculated by mass ratio, the mass ratio of the bioabsorbable polymer to calcium phosphate being from 1 to 99:99 to 1.
  • the bioabsorbable polyester polymer is a high molecular polylactic acid material.
  • the high molecular polylactic acid material is polyglycolide (PLGA), polylactic acid (PLA), poly L lactic acid (PLLA), poly D, L-lactic acid (PDLA), polyglycolide (PGA).
  • PLGA polyglycolide
  • PLA polylactic acid
  • PLLA poly L lactic acid
  • PDLA poly D
  • PGA polyglycolide
  • the calcium phosphate is nano-sized amorphous calcium phosphate (ACP), dicalcium phosphate (DCP), tricalcium phosphate (TCP), hydroxyapatite pentacalcium (HAP), tetracalcium phosphate carbon monoxide (TTCP) One or several of the compositions.
  • ACP nano-sized amorphous calcium phosphate
  • DCP dicalcium phosphate
  • TCP tricalcium phosphate
  • HAP hydroxyapatite pentacalcium
  • TTCP tetracalcium phosphate carbon monoxide
  • the preparation method of the bioabsorbable bone repair material, the amount of the bioabsorbable polyester polymer and the calcium phosphate are passed through a high speed (greater than 1000 rpm) mixer, a twin screw extruder at 100 to 400 ° C Prepared by extrusion; or by chemically adding the amount of bioabsorbable polyester polymer and calcium phosphate (for example, changing the positive and negative charges on the surface of the calcium phosphate, or adding a binder to the composite to increase its aggregation
  • the degree of bonding in the lactic acid polymer, etc., but not limited to these methods is obtained by suspending the nanoparticles in a polymer material.
  • a method for preparing an artificial prosthetic bone obtained by injection molding or additive manufacturing.
  • the injection molding method is specifically:
  • the CT/MRI scan image of the patient's damaged bone is first digitized and converted into a note.
  • the CAD file recognizable by the press is then injection molded into a model of damaged bone at 100-400 ° C on an injection molding machine; the artificial prosthesis is obtained and finally implanted into the injured bone by a bone surgeon.
  • the additive material manufacturing method is specifically:
  • A. Convert the CT/MRI image data of the damaged bone into an STL file using open source software, or a file identifiable by other 3D printers, and establish a model of the damaged bone;
  • the wire processed in B is melted and sintered according to the model established in A, and the artificial prosthesis bone is obtained by layer-by-layer sintering through a 3D printer.
  • the polymer polylactic acid-calcium phosphate composite material wire is melted and layer by layer according to the established bone model through a printer, and finally the prosthesis of the original damaged bone is formed.
  • Printers used in additive manufacturing can be, but are not limited to, fused deposition 3D printers. A variety of 3D printers already on the market can meet the needs of this printing.
  • the outer surface of the artificial prosthesis is coated with a bone growth inducing substance and implanted into the damaged bone.
  • the invention is applicable to any bone damage, especially the skull.
  • the bone growth inducing substance is one or several compositions of the injured patient's own bone marrow stem cells, artificially cultured osteogenic stem cells, osteogenic factors and drugs.
  • the nano calcium phosphate particles are added to the polylactic acid polymer material through a special process to form a polymer polylactic acid-nano calcium phosphate composite material.
  • Calcium phosphate is one of the main components of human bones, also known as bioceramics, with many different combinations, including but not limited to hydroxyapatite (Ca.sub.10(PO.sub.4).sub.6( OH).sub.2), fluoroapatite (Ca.sub.10(PO.sub.4).sub.6F.sub.2), carbonized apatite (Ca.sub.10 (PO.sub.).
  • the polylactic acid/calcium phosphate composite material of the present invention is an ideal material for degradable human bone skull.
  • Skull repair method The repair of skull defect caused by trauma and surgery, etc., unless it is an autologous bone flap, it is very difficult to completely conform to the original defect.
  • the location, size and shape of the skull defect are different, and the traditional mold and hand-made and the defect area are difficult to match before and during the operation.
  • the shaped titanium plate restoration does not conform to the physiological curvature of the original defect area.
  • the cosmetic effect is poor.
  • most clinicians used simple tools to perform on-site processing of titanium mesh. Doctors repeatedly designed, cut, and shaped before and during surgery. Due to the experience of the surgeon and the influence of the manufacturing tools, the surgical results were uneven and delayed. The operation time often fails to achieve a symmetrical cosmetic effect.
  • more than 70% of patients with defect areas in the forehead, eyebrow arch contour and its adjacent frontal dome area the cosmetic effect directly affects the patient's psychological and physical health.
  • the shape is more perfect and more accurate.
  • the digital design and manufacturing technology of titanium alloy skull restorations that have been used clinically.
  • the advantage of this technology is that digital technology combined with CT scanning three-dimensional imaging can make the restoration made before surgery more accurate.
  • the symmetry of the repaired titanium mesh prosthesis and the healthy side of the skull determines the cosmetic effect of the operation.
  • the computer-aided design of the cranioplasty is based on the skull information of the patient's skull CT during the surgical design, and the soft tissue information is discarded. If the implanted material is placed between the scalp and the diaphragm, the implant material designed according to the skull information cannot be matched.
  • 3D printing technology and skull repair 3D printing is the technology of additive manufacturing, relying on 3D CAD design data, the technology of manufacturing solid parts by discrete materials (liquid, powder, silk, etc.). Compared to traditional material removal processing techniques, additive manufacturing is a bottom-up material additive manufacturing process. “Additive manufacturing” eliminates the need for original embryos and molds, and can directly generate objects of any shape by adding materials according to computer graphics data, simplifying the manufacturing process of products, shortening the development cycle of products, improving efficiency and reducing costs. The technical characteristics of 3D determine its outstanding advantages in the field of small-volume customization and complex product manufacturing, such as artificial skull printing.
  • the materials of the present invention have enhanced mechanical strength, good biocompatibility, osteoinductive function, and biodegradability when used for bone repair.
  • the implant implanted in the bone is automatically absorbed by the body after the injury has healed, thereby avoiding the side effects of conventional metal or other non-degradable prosthesis.
  • the manufacturing method of the invention has the advantages of quickness, simplicity and precision, and can rapidly and individually produce an absorbable bone repair prosthesis, thereby benefiting patients with bone injury.
  • FIG. 1 is a flow chart of a 3D printed bioabsorbable skull prosthesis of the present invention
  • FIG. 2 is a diagram showing the nanopore structure of the bioresorbable bone repair material of the present invention.
  • the cross-sections (F and H) of the prosthesis made of the material are microporous structures of nanometers to micrometers, and the micropores are enlarged as the polylactic acid is degraded in the body, which is itself during the bone repair process. The space for bone cell growth.
  • Figure 3 is an implantable device (vascular stent) made of bioresorbable bone repair material (C) and non-degradable PEVA/PBMA (A) and degradable polylactic acid material (B) in the blood vessel of an animal. Comparison of biocompatibility after the month. As shown in the figure, the vascular stent made of the bioabsorbable composite material of the present invention is covered with a thin layer of endothelial cells after being implanted into the blood vessel for one month, and is a manifestation of vascular repair (C, arrow) ), while the rods of PEVA/PBMA and polylactic acid stents are full of proliferating inflammatory tissues (A and B, black lines).
  • A non-absorbable material PEVA/PBMA composite material
  • B high molecular polylactic acid material
  • C polylactic acid/calcium phosphate composite material.
  • Top low power microscope (4X); bottom: high power microscope (20X).
  • FIG 4 is a comparison of the enhanced mechanical strength of the bioabsorbable bone repair material of the present invention. As shown, the bioabsorbable bone repair material (green) of the present invention has significantly enhanced mechanical strength compared to the individual polylactic acid material (blue).
  • FIG. 5 is a schematic diagram showing the process of converting a human body bone tissue series CT tomogram (1 mm/frame) into a 3D printed STL file or an injection moldable CAD file according to the present invention.
  • FIG 6 is a schematic illustration of an artificial skull printed with a bioabsorbable bone restorative material using the additive manufacturing method of the present invention.
  • the bioabsorbable wire of the present invention is printed on the bioabsorbable skull by a 3D printing device, according to the STL file converted in Figure 5.
  • Figure 7 is a clinical repair process for an artificial skull of the present invention.
  • a series of CT scans of the injured skull were performed, and the scanned image was converted into an STL file as shown in Fig. 5, and printed into a complete bioabsorbable skull (as shown in Fig. 6), and finally the lesion was taken out in the printed skull.
  • the artificial bone piece of the site is implanted into the injured part of the patient.
  • the present invention can be applied to any bone injury.
  • the present invention will be further described in detail below with reference to specific embodiments to help those skilled in the art understand the present invention, but is not intended to limit the present invention to other bone injuries. application.
  • a bioresorbable skull repairing material is a composite of 10 kg of bioabsorbable polyester polymer (polyethylene lactide) and calcium phosphate (amorphous calcium phosphate (ACP)) 90 kg .
  • the composite material constituting the absorbable skull prosthesis can be obtained by a polymer and nano processing technology, such as a high-speed mixer, a twin-screw extruder, or the like, or can be obtained by suspending the nanoparticles in a polymer material by a chemical method.
  • the preparation method of the prosthesis bone is an injection molding method:
  • the bioresorbable bone repair material is injection molded into a model of the damaged skull according to the CAD file converted above;
  • the prepared absorbable skull is coated with a bone growth inducing substance (injured patient's own bone marrow stem cells) into the skull of the patient's injury.
  • a bone growth inducing substance injured patient's own bone marrow stem cells
  • a bioabsorbable bone repairing material comprising a composition of 20 kg of a bioabsorbable polyester polymer (polylactic acid (PLA)) and 80 kg of calcium phosphate (dicalcium phosphate (DCP)).
  • PLA polylactic acid
  • DCP calcium phosphate
  • the composite material constituting the absorbable skull prosthesis can be obtained by a polymer and nano processing technology, such as a high-speed mixer, a twin-screw extruder extrusion method, or a chemical method for suspending the nano particles in a polymer material.
  • a polymer and nano processing technology such as a high-speed mixer, a twin-screw extruder extrusion method, or a chemical method for suspending the nano particles in a polymer material.
  • A. Convert the CT/MRI image data of the damaged skull into an STL file using open source software, or a file recognizable by other 3D printers, and establish a model of the damaged skull;
  • the wire processed in B is melted and sintered according to the model established in A, and laminated by the 3D printer to form the absorbable artificial skull prosthesis.
  • the prepared absorbable skull is coated with a bone growth inducing substance (osteogenic stem cells cultured in vitro) into the injured skull of the patient.
  • a bone growth inducing substance osteogenic stem cells cultured in vitro
  • a bioabsorbable bone repairing material is a composite of 30 kg of bioabsorbable polyester polymer (poly L lactic acid (PLLA)) and calcium phosphate (tricalcium phosphate (TCP)) 70 kg .
  • bioabsorbable polyester polymer poly L lactic acid (PLLA)
  • PLLA poly L lactic acid
  • TCP calcium phosphate
  • the preparation method is the same as in the first embodiment, and the prepared absorbable skull bone piece is implanted into the injured skull of the patient.
  • a bioabsorbable bone repairing material is bioabsorbable polyester polymer (poly D, L-lactic acid (PDLA)) 40 kg and calcium phosphate (hydroxyapatite pentacalcium (HAP) )) 60 kg of composite, the surface of the prosthesis is also coated with a bone growth inducing substance (drug).
  • PDLA poly D, L-lactic acid
  • HAP calcium phosphate
  • the preparation method was the same as in Example 2.
  • the prepared absorbable skull was coated with a bone growth inducing substance (osteogenic factor) into the injured skull of the patient.
  • a bioabsorbable bone repairing material the component of the skull repair prosthesis being bioabsorbable 50 kg of a polyester polymer (poly D, L-glycolide) complex with calcium phosphate (tetracalcium phosphate monocarbonate (TTCP)) 50 kg.
  • a polyester polymer poly D, L-glycolide
  • calcium phosphate tetracalcium phosphate monocarbonate (TTCP)
  • the preparation method was the same as in Example 2.
  • the prepared absorbable skull was coated with a bone growth inducing substance (injured patient's own bone marrow stem cells) into the skull of the patient's injury.
  • the composition of the skull repair prosthesis is bioabsorbable polyester polymer (polyethylene glycol (PLGA) 20kg, polylactic acid (PLA) 20kg, poly L lactic acid (PLLA) 20kg) 60kg complex with calcium phosphate (amorphous calcium phosphate (ACP) 20kg, hydroxyapatite pentacalcium (HAP) 20kg) 40kg
  • the preparation method was the same as in Example 2.
  • the prepared absorbable skull was coated with a bone growth inducing substance (osteogenic factor + drug) into the injured skull of the patient.
  • the composition of the skull repair prosthesis is bioabsorbable polyester polymer (poly L-lactic acid (PLLA) 10kg, poly D, L-lactic acid (PDLA) 20kg, polyglycolide (PGA) 20kg, poly D, L-glycolide 20kg) 70kg and calcium phosphate (hydroxyapatite pentacalcium (HAP)) 30kg complex.
  • PLLA poly L-lactic acid
  • PDLA poly D, L-lactic acid
  • PGA polyglycolide
  • HAP calcium phosphate
  • the preparation method is the same as in the first embodiment, and the prepared absorbable skull is coated with a bone growth inducing substance (damaged patient's own bone marrow stem cells) into the skull of the patient's injury.
  • a bone growth inducing substance damaged patient's own bone marrow stem cells
  • a bioresorbable bone repairing material is a bioabsorbable polyester polymer (polyglycolide (PGA)) 80 kg and calcium phosphate (amorphous calcium phosphate (ACP) 5 kg, phosphoric acid Dicalcium (DCP) 15kg) 20kg complex.
  • PGA polyglycolide
  • ACP amorphous calcium phosphate
  • DCP phosphoric acid Dicalcium
  • the preparation method was the same as in Example 2.
  • the prepared absorbable skull was coated with a bone growth inducing substance (osteogenic stem cells cultured in vitro) into the injured skull of the patient.
  • a bioresorbable bone repairing material is a bioabsorbable polyester polymer (polylactic acid (PLA) 10kg, polyglycolide (PGA) 80kg) 90kg and calcium phosphate (hydroxyl Apatite Pentacalcium (HAP) 10kg complex.
  • PLA polylactic acid
  • PGA polyglycolide
  • HAP calcium phosphate
  • the preparation method is the same as in the second embodiment, and the prepared absorbable skull is coated with a bone growth inducing substance (damaged patient's own bone marrow stem cells) into the skull of the patient's injury.
  • a bone growth inducing substance damaged patient's own bone marrow stem cells

Abstract

A bioresorbable bone repair material and an application and manufacturing method thereof. The bioresorbable bone repair material comprises a bioresorbable polyester polymer and calcium phosphate. The material is prepared by extrusion or a chemical method, and can be further manufactured as a bone prosthesis via injection molding or an additive manufacturing (3D printing) method according to requirements. The bone prosthesis can have a surface coated with an osteoinductivity improving substance and is used to repair bone damages due to a variety of causes.

Description

一种生物可吸收骨修复材料及其应用与制作方法Bioresorbable bone repairing material and application and manufacturing method thereof 技术领域Technical field
本发明属于人工假体技术领域,具体涉及生物可吸收骨修复材料及其在骨修复中应用与制作方法。The invention belongs to the technical field of artificial prosthesis, and particularly relates to a bioresorbable bone repairing material and a method and a manufacturing method thereof for bone repair.
背景技术Background technique
床上各种原因所致的骨缺损十分常见。据估计我国每年在交通事故和生产安全事故中所致创伤骨折、脊柱退行性疾病及骨肿瘤、骨结核等骨科疾病,造成骨缺损或功能障碍患者超过300万人。临床上对骨缺损进行修补成形已成为骨外科医生的共识。Bone defects caused by various reasons on the bed are very common. It is estimated that in China, traumatic fractures, spinal degenerative diseases, bone tumors, bone tuberculosis and other orthopedic diseases are caused by traffic accidents and production safety accidents each year, causing more than 3 million patients with bone defects or dysfunction. The clinical repair of bone defects has become the consensus of bone surgeons.
临床上对理想的骨修复材料的要求包括:(1)良好的生物兼容性:除满足医用材料的一般要求(如无毒、不致畸等)之外,还要利于种子细胞黏附、增殖,降解产物对细胞无毒副作用,不引起炎症反应,甚至利于细胞生长和分化;(2)良好的生物降解性:基质材料在完成支架作用后应能降解,降解率应与组织细胞生长率相适应,降解时间应能根据组织生长特性作人为调控;(3)具有三维立体多孔结构:基质材料可加工成三维立体结构,利于细胞黏附及细胞外基质沉积,营养和氧气进人,代谢产物排出,也有利于血管和神经长入;(4)可塑性和一定的机械强度:基质材料具有良好的可塑性,可预先制作成一定形状。并具有一定的机械强度,为新生组织提供支撑,并保持一定时间直至新生组织具有自身生物力学特性:(5)骨引导活性:骨组织工程材料首先耍考虑其骨诱导性和骨传导性;(6)易消毒性。Clinical requirements for ideal bone repair materials include: (1) Good biocompatibility: in addition to meeting the general requirements of medical materials (such as non-toxic, non-teratogenic, etc.), it is also conducive to seed cell adhesion, proliferation, degradation The product has no toxic and side effects on cells, does not cause inflammatory reaction, and even facilitates cell growth and differentiation; (2) Good biodegradability: the matrix material should be degraded after completion of the scaffold, and the degradation rate should be compatible with the growth rate of the tissue cells. The degradation time should be artificially regulated according to the growth characteristics of the tissue; (3) It has a three-dimensional porous structure: the matrix material can be processed into a three-dimensional structure, which is beneficial to cell adhesion and extracellular matrix deposition, nutrition and oxygen into the human body, and metabolites are discharged. Conducive to vascular and nerve ingrowth; (4) Plasticity and certain mechanical strength: The matrix material has good plasticity and can be pre-made into a certain shape. It has a certain mechanical strength, provides support for new tissue, and maintains a certain time until the new tissue has its own biomechanical properties: (5) Bone guiding activity: bone tissue engineering materials first consider its osteoinductive and osteoconductivity; 6) Easy to disinfect.
传统的骨修补材料主要有有机玻璃、甲基丙烯酸甲酯骨水泥、钛板、硅橡胶板、高分子纤维增强材料和双醋酚丙烯酸酯类微孔可塑性人工骨等。这些材料大多存在组织兼容性差、不耐压,不隔温/防寒及难以塑形、加工等缺点。 The traditional bone repair materials mainly include plexiglass, methyl methacrylate bone cement, titanium plate, silicone rubber plate, polymer fiber reinforced material and diacetal acrylate microporous plastic artificial bone. Most of these materials have shortcomings such as poor tissue compatibility, no pressure resistance, no temperature/cold protection, difficulty in shaping, and processing.
至今,应用较多的人工材料主要是钛合金,由于钛合金材料无毒,致炎及致敏性低,具有良好的生物兼容性和较低的生物蜕变性,耐腐蚀性高等特点,得到越来越广泛的临床应用。由于钛网具有较强的抗压性能,组织兼容性好,植入人体后,成纤维细胞可以长入钛网的微孔,使钛网与组织融为一体,且有钙化和骨化趋势,是比较理想的人工修补材料。钛合金网虽然在外形美观方面较好,但价格昂贵、难以加工且不可降解,病人需终身携带。截至目前,还没有一种材料能完全符合条件,相比而言,有学者认为自体颅骨是修补颅骨缺损最理想的材料。最早应用的自体颅骨,仍在临床应用中占据着重要地位。自体颅骨符合自身生理,不存在免疫排斥反应,很少发生感染、积液、松动等人工材料常见的并发症。普通低温保存的自体颅骨植入后可以存活,尤其适用于儿童,而人工材料不可能随头颅的增大而增大。自体颅骨具有经济、不需塑形的优点,但其组织兼容性,骨瓣离体后是否还具有正常的生理特点,以及骨膜成骨细胞是否还存活均不明确,此外,还有骨瓣移植后吸收和增生等问题值得进一步研究。Up to now, the most used artificial materials are mainly titanium alloys. Because titanium alloy materials are non-toxic, have low inflammation and sensitization, have good biocompatibility, low biodegradability and high corrosion resistance. The wider the clinical application. Because the titanium mesh has strong compressive performance and good tissue compatibility, after being implanted into the human body, the fibroblasts can grow into the micropores of the titanium mesh, so that the titanium mesh and the tissue are integrated, and there is a tendency of calcification and ossification. It is an ideal artificial repair material. Although the titanium alloy mesh is better in appearance, it is expensive, difficult to process and non-degradable, and the patient needs to carry it for life. As of now, no material can fully meet the requirements. In contrast, some scholars believe that the autologous skull is the most ideal material for repairing skull defects. The earliest applied autologous skull still occupies an important position in clinical applications. The autologous skull conforms to its own physiology, there is no immune rejection, and there are few common complications of artificial materials such as infection, effusion, and loosening. Ordinary cryopreservation of the autologous skull can survive after implantation, especially for children, and artificial materials cannot increase with the increase of the skull. The autologous skull has the advantages of economy and no need to shape, but its tissue compatibility, whether the bone flap has normal physiological characteristics after ex vivo, and whether the periosteal osteoblasts still survive is not clear. In addition, there is bone flap transplantation. Post-absorption and hyperplasia issues deserve further study.
高分子聚乳酸(polylactide,PLA)具有较好的热成型性,通过调节分子量和结构等可调节其降解速度,以满足不同的临床要求,故在骨组织工程领域中能基本满足作为细胞生长载体材料的要求,但聚乳酸材料机械强度较差,且降解产物略呈酸性,由其的制成植入器械/修复材料存有两大缺点:其一,聚乳酸材料在体内降解时会产生酸性产物,该些产物会使植入周边组织发生非感染性炎症(生物兼容性差);其二,现有聚乳酸材料缺乏足够的机械强度来满足人体器官,尤其是骨器官的正常需求。磷酸钙是天然骨的主要无机成分,在骨质中大约占60wt%,其基本单元是针状磷灰石晶体,植入人体后能在短时间内与人体的软硬组织形成紧密结合,是一种性能非常优秀的骨修复材料。但磷灰石单晶体易碎、强度差、韧性差及不易加工等缺点制约了其在临床的临床应用。 Polylactide (PLA) has good thermoformability, and its degradation rate can be adjusted by adjusting molecular weight and structure to meet different clinical requirements. Therefore, it can basically satisfy the cell growth carrier in the field of bone tissue engineering. The requirements of the material, but the polylactic acid material has poor mechanical strength, and the degradation product is slightly acidic. There are two major disadvantages in the preparation of the implanted/repaired material: First, the polylactic acid material will be acidic when degraded in the body. Products that cause non-infectious inflammation (poor biocompatibility) in implanted peripheral tissues; second, existing polylactic acid materials lack sufficient mechanical strength to meet the normal needs of human organs, especially bone organs. Calcium phosphate is the main inorganic component of natural bone. It accounts for about 60% by weight in bone. Its basic unit is acicular apatite crystal. It can be tightly combined with the soft and hard tissues of human body in a short time after being implanted into human body. It is a very good bone repair material. However, the apatite single crystal is fragile, poor strength, poor toughness and difficult to process, which restricts its clinical application.
发明内容Summary of the invention
为了解决上述问题,本发明的目的在于提供一种生物可吸收骨修复材料,该材料既能满足骨修补材料应具备的条件,同时具有较好的生物兼容性,足够的机械强度及骨诱导功能。In order to solve the above problems, an object of the present invention is to provide a bioabsorbable bone repairing material which can satisfy the conditions for a bone repairing material, has good biocompatibility, sufficient mechanical strength and osteoinductive function. .
本发明的目的之二提供了所述生物可吸收骨修复材料的应用及其制作方法。The second object of the present invention provides the use of the bioabsorbable bone repair material and a method of making the same.
本发明的目的之三提供了一中人工假体骨。The third object of the present invention provides a prosthetic bone.
本发明是通过以下技术方案来实现的:The present invention is achieved by the following technical solutions:
一种生物可吸收骨修复材料,包括按质量比计算的生物可吸收聚酯聚合物和磷酸钙,所述生物可吸收聚合物与磷酸钙的质量比为1~99∶99~1。A bioabsorbable bone restorative material comprising a bioabsorbable polyester polymer and calcium phosphate calculated by mass ratio, the mass ratio of the bioabsorbable polymer to calcium phosphate being from 1 to 99:99 to 1.
较佳地,所述生物可吸收聚酯聚合物为高分子聚乳酸材料。Preferably, the bioabsorbable polyester polymer is a high molecular polylactic acid material.
较佳地,所述高分子聚乳酸材料为聚乙丙交酯(PLGA)、聚乳酸(PLA)、聚L乳酸(PLLA)、聚D,L-乳酸(PDLA)、聚乙交酯(PGA)、聚D,L-乙交酯中的一种或几种组合物。Preferably, the high molecular polylactic acid material is polyglycolide (PLGA), polylactic acid (PLA), poly L lactic acid (PLLA), poly D, L-lactic acid (PDLA), polyglycolide (PGA). One or several compositions of poly D, L-glycolide.
较佳地,所述磷酸钙为纳米级别的无定形磷酸钙(ACP)、磷酸二钙(DCP)、磷酸三钙(TCP)、羟基磷灰石五钙(HAP)、磷酸四钙一氧化碳(TTCP)中的一种或几种组合物。Preferably, the calcium phosphate is nano-sized amorphous calcium phosphate (ACP), dicalcium phosphate (DCP), tricalcium phosphate (TCP), hydroxyapatite pentacalcium (HAP), tetracalcium phosphate carbon monoxide (TTCP) One or several of the compositions.
所述生物可吸收骨修复材料的制备方法,将所述量的生物可吸收聚酯聚合物和磷酸钙通过高速(大于1000转/分)混合器、双螺杆挤出机于100~400℃下挤出制得;或将所述量生物可吸收聚酯聚合物和磷酸钙通过化学方法(例如,改变磷酸钙表面的正负电荷,或在复合材料中添加粘合剂,以增加其在聚乳酸高分子内的结合度等,但不限于这些方法)将纳米微粒悬浮于高分子材料中获得。The preparation method of the bioabsorbable bone repair material, the amount of the bioabsorbable polyester polymer and the calcium phosphate are passed through a high speed (greater than 1000 rpm) mixer, a twin screw extruder at 100 to 400 ° C Prepared by extrusion; or by chemically adding the amount of bioabsorbable polyester polymer and calcium phosphate (for example, changing the positive and negative charges on the surface of the calcium phosphate, or adding a binder to the composite to increase its aggregation The degree of bonding in the lactic acid polymer, etc., but not limited to these methods) is obtained by suspending the nanoparticles in a polymer material.
一种人工假体骨的制备方法,将所述生物可吸收骨修复材料通过注塑法或增材制作法制备而得。A method for preparing an artificial prosthetic bone obtained by injection molding or additive manufacturing.
其中,所述注塑法具体为:Wherein, the injection molding method is specifically:
由注塑法制作时,先将病人损伤骨的CT/MRI等扫面影像数字化,转化为注 塑机可识别的CAD文件,然后在注塑机上于100~400℃下注塑成损伤骨的模型;得到所述人工假体,最后由骨外科医生将其植入损伤的骨骼内。When the injection molding method is used, the CT/MRI scan image of the patient's damaged bone is first digitized and converted into a note. The CAD file recognizable by the press is then injection molded into a model of damaged bone at 100-400 ° C on an injection molding machine; the artificial prosthesis is obtained and finally implanted into the injured bone by a bone surgeon.
所述增材料制造法具体为:The additive material manufacturing method is specifically:
A、将损伤骨的CT/MRI影像资料用开源软件转化为STL文件,或其他3D打印机可识别的文件,建立损伤骨之模型;A. Convert the CT/MRI image data of the damaged bone into an STL file using open source software, or a file identifiable by other 3D printers, and establish a model of the damaged bone;
B、将所述生物可吸收骨修复材料加工成3D打印机可使用的线材;B. processing the bioabsorbable bone repair material into a wire that can be used in a 3D printer;
C、用融溶烧结法将B中加工成的线材,按A中建立的模型,通过3D打印机逐层烧结叠加成得到所述人工假体骨。C. The wire processed in B is melted and sintered according to the model established in A, and the artificial prosthesis bone is obtained by layer-by-layer sintering through a 3D printer.
3D打印时,将高分子聚乳酸-磷酸钙复合材料线材,通过打印机,按所建立的骨模型,逐层熔融迭加,最后拟向形成原损伤骨的假体。增材制作所采用的打印机可为但不限于熔融沉积3D打印机。市场上已有的多款3D打印机均可满足本打印的需求。In 3D printing, the polymer polylactic acid-calcium phosphate composite material wire is melted and layer by layer according to the established bone model through a printer, and finally the prosthesis of the original damaged bone is formed. Printers used in additive manufacturing can be, but are not limited to, fused deposition 3D printers. A variety of 3D printers already on the market can meet the needs of this printing.
所述人工假体骨的应用,将所述人工假体骨外表面涂覆上骨生长诱导物质,植入到损伤的骨头处。本发明适用于任何骨损伤,尤其是颅骨。In the application of the artificial prosthesis bone, the outer surface of the artificial prosthesis is coated with a bone growth inducing substance and implanted into the damaged bone. The invention is applicable to any bone damage, especially the skull.
所述人工假体骨的应用,所述骨生长诱导物质为损伤病人自身骨髓干细胞、人工体外培养的成骨干细胞、成骨因子及药物中的一种或几种组合物。In the application of the artificial prosthesis bone, the bone growth inducing substance is one or several compositions of the injured patient's own bone marrow stem cells, artificially cultured osteogenic stem cells, osteogenic factors and drugs.
本发明将纳米磷酸钙颗粒通过特殊的工艺添加至聚乳酸高分子材料中,形成高分子聚乳酸-纳米磷酸钙复合材料。磷酸钙是人体骨骼的主要成分之一,又被称为生物陶瓷,含多种不同组合,包括但不限于羟基磷灰石(Ca.sub.10(PO.sub.4).sub.6(OH).sub.2)、氟磷灰石(Ca.sub.10(PO.sub.4).sub.6F.sub.2)、碳化磷灰石(Ca.sub.10(PO.sub.4).sub.6CO.sub.3)、磷酸三钙(Ca.sub.3(PO.sub.4).sub.2)、磷酸八钙(Ca.sub.8H.sub.2(PO.sub.4)6-5H.sub.2O)、焦磷酸钙(Ca.sub.2P.sub.2O.sub.7-2H.sub.2O)、磷酸四钙(Ca.sub.4P.sub.2O.sub.9)与磷酸氢钙二水合物(CaHPO.sub.4-2H.sub.2O)。磷酸钙呈弱碱性,与高分子聚乳酸结合后,能中和聚乳酸材料的酸性降解产物而改善其生物兼容性。磷酸 钙能调节聚乳酸高分子材料空间结构,而增加复合材料机械强度;聚乳酸/磷酸钙共混后的复合材料呈纳米微孔结构,该微孔结构也能诱导骨的快速生长。因而本发明中的聚乳酸/磷酸钙复合材料是用于可降解人骨颅骨的理想材料。In the invention, the nano calcium phosphate particles are added to the polylactic acid polymer material through a special process to form a polymer polylactic acid-nano calcium phosphate composite material. Calcium phosphate is one of the main components of human bones, also known as bioceramics, with many different combinations, including but not limited to hydroxyapatite (Ca.sub.10(PO.sub.4).sub.6( OH).sub.2), fluoroapatite (Ca.sub.10(PO.sub.4).sub.6F.sub.2), carbonized apatite (Ca.sub.10 (PO.sub. 4).sub.6CO.sub.3), tricalcium phosphate (Ca.sub.3 (PO.sub.4).sub.2), octacalcium phosphate (Ca.sub.8H.sub.2 (PO. Sub.4)6-5H.sub.2O), calcium pyrophosphate (Ca.sub.2P.sub.2O.sub.7-2H.sub.2O), tetracalcium phosphate (Ca.sub.4P.sub. 2O.sub.9) with calcium hydrogen phosphate dihydrate (CaHPO.sub.4-2H.sub.2O). Calcium phosphate is weakly alkaline, and when combined with high molecular polylactic acid, it can neutralize the acidic degradation products of polylactic acid materials and improve its biocompatibility. Phosphate Calcium can adjust the spatial structure of polylactic acid polymer material, and increase the mechanical strength of the composite; the composite material of polylactic acid/calcium phosphate blend has nano-microporous structure, and the microporous structure can also induce rapid bone growth. Thus, the polylactic acid/calcium phosphate composite material of the present invention is an ideal material for degradable human bone skull.
其中:among them:
颅骨修补方法:因创伤及手术等因素造成的颅骨缺损的修复,除非是自体骨瓣,在形态上做到与原缺损部位完全一致十分困难。颅骨缺损的部位、大小、形状各不相同,且术前及术中进行传统模具和手工制作与缺损区难以十分匹配,特别是塑形的钛板修复体与原缺损区生理曲度不符,成形后左右对称性欠佳,美容效果差。既往多数临床医生采用简单工具对钛网进行现场加工制作,医生在术前和术中反复设计、裁剪、塑形,由于术者的经验和制作工具的影响,导致手术效果参差不齐,既延误了手术时间,往往又达不到对称的美容效果。而且70%以上的患者缺损区域在前额、眉弓轮廓及其相邻的额颞顶区域,美容效果直接影响到患者的心理和生理的健康。Skull repair method: The repair of skull defect caused by trauma and surgery, etc., unless it is an autologous bone flap, it is very difficult to completely conform to the original defect. The location, size and shape of the skull defect are different, and the traditional mold and hand-made and the defect area are difficult to match before and during the operation. In particular, the shaped titanium plate restoration does not conform to the physiological curvature of the original defect area. After the left and right symmetry is not good, the cosmetic effect is poor. In the past, most clinicians used simple tools to perform on-site processing of titanium mesh. Doctors repeatedly designed, cut, and shaped before and during surgery. Due to the experience of the surgeon and the influence of the manufacturing tools, the surgical results were uneven and delayed. The operation time often fails to achieve a symmetrical cosmetic effect. Moreover, more than 70% of patients with defect areas in the forehead, eyebrow arch contour and its adjacent frontal dome area, the cosmetic effect directly affects the patient's psychological and physical health.
随着计算机和三维图像重建技术的应用以及采用自动模具制作钛板,使塑形更完美、更精确。目前已在临床使用的钛合金颅骨修复体的数字化设计与制造技术,这种技术的优点是数字技术结合CT扫描三维成像,能使术前制成的修复体更精确。修补术后钛网修复体与健侧颅骨的对称性决定着手术的美容效果,但是计算机辅助设计的颅骨成形术在手术设计时,只是根据患者头颅CT的颅骨信息进行的,舍弃了软组织的信息,若将植入的材料放在头皮和颞肌之间,则根据颅骨信息设计的植入材料就无法匹配。With the application of computer and 3D image reconstruction technology and the use of automatic mold to make titanium plates, the shape is more perfect and more accurate. The digital design and manufacturing technology of titanium alloy skull restorations that have been used clinically. The advantage of this technology is that digital technology combined with CT scanning three-dimensional imaging can make the restoration made before surgery more accurate. The symmetry of the repaired titanium mesh prosthesis and the healthy side of the skull determines the cosmetic effect of the operation. However, the computer-aided design of the cranioplasty is based on the skull information of the patient's skull CT during the surgical design, and the soft tissue information is discarded. If the implanted material is placed between the scalp and the diaphragm, the implant material designed according to the skull information cannot be matched.
3D打印技术与颅骨修复:3D打印即增材制造技术,依靠三维CAD设计数据,将离散材料(液体、粉末、丝等)逐层累加原理制造实体零件的技术。相对于传统的材料去除加工技术,增材制造是一种自下而上材料累加制造工艺。“增材制造”无需原胚和模具,就能直接根据计算机图形数据,通过增加材料的方法生成任何形状的物体,简化产品的制造程序,缩短产品的研制周期,提高效率并降低成本。3D的技术特点决定了其在小批量定制及复杂产品的制造领域,如人工颅骨打印等领域具突出优势。 3D printing technology and skull repair: 3D printing is the technology of additive manufacturing, relying on 3D CAD design data, the technology of manufacturing solid parts by discrete materials (liquid, powder, silk, etc.). Compared to traditional material removal processing techniques, additive manufacturing is a bottom-up material additive manufacturing process. “Additive manufacturing” eliminates the need for original embryos and molds, and can directly generate objects of any shape by adding materials according to computer graphics data, simplifying the manufacturing process of products, shortening the development cycle of products, improving efficiency and reducing costs. The technical characteristics of 3D determine its outstanding advantages in the field of small-volume customization and complex product manufacturing, such as artificial skull printing.
综合上述,本发明所涉及的材料,用于骨修复时,具增强的机械强度、良好的生物兼容性、骨诱导功能及生物可降解性。植入骨内的假体在损伤愈合后被机体自动吸收,从而避免了传统金属或其他不可降解修复假体所具有的副作用。本发明所涉及的制作方法具快速、简单、精确的优点,在临床上,可快速、个性化生产可吸收骨修复假体,从而造福骨损伤病人。In summary, the materials of the present invention have enhanced mechanical strength, good biocompatibility, osteoinductive function, and biodegradability when used for bone repair. The implant implanted in the bone is automatically absorbed by the body after the injury has healed, thereby avoiding the side effects of conventional metal or other non-degradable prosthesis. The manufacturing method of the invention has the advantages of quickness, simplicity and precision, and can rapidly and individually produce an absorbable bone repair prosthesis, thereby benefiting patients with bone injury.
附图说明DRAWINGS
图1为本发明3D打印生物可吸收颅骨假体方法流程图;1 is a flow chart of a 3D printed bioabsorbable skull prosthesis of the present invention;
图2为本发明生物可吸收骨修复材料纳米微孔结构图。如图中所示,由本材料所制成假体的断面(F和H)成纳米到微米级的微孔结构,该些微孔随聚乳酸在体内降解而加大,是骨修复过程中自身骨细胞生长的空间。2 is a diagram showing the nanopore structure of the bioresorbable bone repair material of the present invention. As shown in the figure, the cross-sections (F and H) of the prosthesis made of the material are microporous structures of nanometers to micrometers, and the micropores are enlarged as the polylactic acid is degraded in the body, which is itself during the bone repair process. The space for bone cell growth.
图3为本发明中的生物可吸收骨修复材料(C)与不可降解PEVA/PBMA(A)及可降解聚乳酸材料(B)所制成的植入器械(血管支架)在动物血管内一个月后的生物兼容性比较。如图中所示,本发明中的生物可吸收复合材料所制血管支架,在植入动物血管一个月后,其表面覆盖一层薄薄的内皮细胞,是血管修复的表现(C下,箭头),而PEVA/PBMA及聚乳酸支架的杆内则长满增生的炎症组织(A和B下,黑线)。图中A:不可吸收材料PEVA/PBMA复合材料;B:高分子聚乳酸材料;C:聚乳酸/磷酸钙复合材料。上:低倍显微镜(4X);下:高倍显微镜(20X)。Figure 3 is an implantable device (vascular stent) made of bioresorbable bone repair material (C) and non-degradable PEVA/PBMA (A) and degradable polylactic acid material (B) in the blood vessel of an animal. Comparison of biocompatibility after the month. As shown in the figure, the vascular stent made of the bioabsorbable composite material of the present invention is covered with a thin layer of endothelial cells after being implanted into the blood vessel for one month, and is a manifestation of vascular repair (C, arrow) ), while the rods of PEVA/PBMA and polylactic acid stents are full of proliferating inflammatory tissues (A and B, black lines). In the figure, A: non-absorbable material PEVA/PBMA composite material; B: high molecular polylactic acid material; C: polylactic acid/calcium phosphate composite material. Top: low power microscope (4X); bottom: high power microscope (20X).
图4为本发明中的生物可吸收骨修复材料增强的机械强度比较。如图所示,本发明中的生物可吸收骨修复材料(绿色)与单独聚乳酸材料(蓝色)相比具明显增强机械强度。Figure 4 is a comparison of the enhanced mechanical strength of the bioabsorbable bone repair material of the present invention. As shown, the bioabsorbable bone repair material (green) of the present invention has significantly enhanced mechanical strength compared to the individual polylactic acid material (blue).
图5为本发明中将人体骨骼组织系列CT断层扫描图(1mm/帧)转化为可3D打印STL文件或可注塑CAD文件过程示意图。FIG. 5 is a schematic diagram showing the process of converting a human body bone tissue series CT tomogram (1 mm/frame) into a 3D printed STL file or an injection moldable CAD file according to the present invention.
图6为用本发明的增材制作法,将生物可吸收骨修复材料打印成的人工颅骨的示意图。如图所示,将本发明中的生物可吸收线材,通过3D打印装置,按图5中转化所得的STL文件,打印的生物可吸收颅骨。 Figure 6 is a schematic illustration of an artificial skull printed with a bioabsorbable bone restorative material using the additive manufacturing method of the present invention. As shown, the bioabsorbable wire of the present invention is printed on the bioabsorbable skull by a 3D printing device, according to the STL file converted in Figure 5.
图7为本发明用于人工颅骨的临床修复过程。如图所示,将损伤颅骨进行系列CT扫描,将扫描影像按图5所示转化为STL文件,并打印成一完整生物可吸收颅骨(如图6所示),最后在打印的颅骨中取出损伤部位的人工骨片,并将其植入到病人的损伤部位。Figure 7 is a clinical repair process for an artificial skull of the present invention. As shown in the figure, a series of CT scans of the injured skull were performed, and the scanned image was converted into an STL file as shown in Fig. 5, and printed into a complete bioabsorbable skull (as shown in Fig. 6), and finally the lesion was taken out in the printed skull. The artificial bone piece of the site is implanted into the injured part of the patient.
具体的实施方式Specific embodiment
本发明可以用于任何骨损伤,下面以颅骨为例结合具体实施方式对本发明作进一步的详细说明,以助于本领域技术人员理解本发明,但并不用来限制本发明在其它骨损伤中的应用。The present invention can be applied to any bone injury. The present invention will be further described in detail below with reference to specific embodiments to help those skilled in the art understand the present invention, but is not intended to limit the present invention to other bone injuries. application.
实施例1Example 1
一种生物可吸收颅骨修复材料,所述颅骨修复假体的组成成分为生物可吸收聚酯聚合物(聚乙丙交酯)10kg与磷酸钙(无定形磷酸钙(ACP))90kg的复合物。A bioresorbable skull repairing material, the composition of the skull repair prosthesis is a composite of 10 kg of bioabsorbable polyester polymer (polyethylene lactide) and calcium phosphate (amorphous calcium phosphate (ACP)) 90 kg .
构成可吸收颅骨假体的复合材料可由高分子及纳米加工技术,如高速混合器,双螺杆挤出机挤出等方法制得,或通过化学方法将将纳米微粒悬浮于高分子材料中获得。The composite material constituting the absorbable skull prosthesis can be obtained by a polymer and nano processing technology, such as a high-speed mixer, a twin-screw extruder, or the like, or can be obtained by suspending the nanoparticles in a polymer material by a chemical method.
所述假体骨的制备方法,为注塑法:The preparation method of the prosthesis bone is an injection molding method:
A、将损伤颅骨的CT/MRI图像数字化,转化为CAD文件;A. Digitize the CT/MRI image of the injured skull and convert it into a CAD file;
B、在注塑机上,按上述转化的CAD文件,将上述生物可吸收骨修复材料注塑成损伤颅骨的模型;B. On the injection molding machine, the bioresorbable bone repair material is injection molded into a model of the damaged skull according to the CAD file converted above;
将制得的可吸收颅骨涂上骨生长诱导物质(损伤病人自身骨髓干细胞)植入病人损伤的颅骨内。The prepared absorbable skull is coated with a bone growth inducing substance (injured patient's own bone marrow stem cells) into the skull of the patient's injury.
实施例2Example 2
一种生物可吸收骨修复材料,所述颅骨修复假体的组成成分为生物可吸收聚酯聚合物(聚乳酸(PLA))20kg与磷酸钙(磷酸二钙(DCP))80kg的复合物。 A bioabsorbable bone repairing material comprising a composition of 20 kg of a bioabsorbable polyester polymer (polylactic acid (PLA)) and 80 kg of calcium phosphate (dicalcium phosphate (DCP)).
构成可吸收颅骨假体的复合材料可由高分子及纳米加工技术,如高速混合器,双螺杆挤出机挤出等方法制得,或通过化学方法将纳米微粒悬浮于高分子材料中获得。The composite material constituting the absorbable skull prosthesis can be obtained by a polymer and nano processing technology, such as a high-speed mixer, a twin-screw extruder extrusion method, or a chemical method for suspending the nano particles in a polymer material.
所述假体骨的制备方法:The preparation method of the prosthesis bone:
A、将损伤颅骨的CT/MRI影像资料用开源软件转化为STL文件,或其他3D打印机可识别的文件,建立损伤颅骨之模型;A. Convert the CT/MRI image data of the damaged skull into an STL file using open source software, or a file recognizable by other 3D printers, and establish a model of the damaged skull;
B、将所述生物可吸收骨修复材料加工成3D打印机可使用的线材。B. Processing the bioabsorbable bone repair material into a wire that can be used in a 3D printer.
C、用融溶烧结法将B中加工成的线材,按A中建立的模型,通过3D打印机逐层烧结叠加成所发明的可吸收人工颅骨假体。C. The wire processed in B is melted and sintered according to the model established in A, and laminated by the 3D printer to form the absorbable artificial skull prosthesis.
将制得的可吸收颅骨,涂上骨生长诱导物质(人工体外培养的成骨干细胞)植入病人损伤的颅骨内。The prepared absorbable skull is coated with a bone growth inducing substance (osteogenic stem cells cultured in vitro) into the injured skull of the patient.
实施例3Example 3
一种生物可吸收骨修复材料,所述颅骨修复假体的组成成分为生物可吸收聚酯聚合物(聚L乳酸(PLLA))30kg与磷酸钙(磷酸三钙(TCP))70kg的复合物。A bioabsorbable bone repairing material, the composition of the skull repair prosthesis is a composite of 30 kg of bioabsorbable polyester polymer (poly L lactic acid (PLLA)) and calcium phosphate (tricalcium phosphate (TCP)) 70 kg .
制备方法同实施例1,将制得的可吸收颅骨骨片植入病人损伤的颅骨内。The preparation method is the same as in the first embodiment, and the prepared absorbable skull bone piece is implanted into the injured skull of the patient.
实施例4Example 4
一种生物可吸收骨修复材料,所述颅骨修复假体的组成成分为生物可吸收聚酯聚合物(聚D,L-乳酸(PDLA))40kg与磷酸钙(羟基磷灰石五钙(HAP))60kg的复合物,所述假体表面还涂有骨生长诱导物质(药物)。A bioabsorbable bone repairing material, the composition of the skull repair prosthesis is bioabsorbable polyester polymer (poly D, L-lactic acid (PDLA)) 40 kg and calcium phosphate (hydroxyapatite pentacalcium (HAP) )) 60 kg of composite, the surface of the prosthesis is also coated with a bone growth inducing substance (drug).
制备方法同实施例2,将制得的可吸收颅骨,涂上骨生长诱导物质(成骨因子)植入病人损伤的颅骨内。The preparation method was the same as in Example 2. The prepared absorbable skull was coated with a bone growth inducing substance (osteogenic factor) into the injured skull of the patient.
实施例5Example 5
一种生物可吸收骨修复材料,所述颅骨修复假体的组成成分为生物可吸收 聚酯聚合物(聚D,L-乙交酯)50kg与磷酸钙(磷酸四钙一氧化碳(TTCP))50kg的复合物。A bioabsorbable bone repairing material, the component of the skull repair prosthesis being bioabsorbable 50 kg of a polyester polymer (poly D, L-glycolide) complex with calcium phosphate (tetracalcium phosphate monocarbonate (TTCP)) 50 kg.
制备方法同实施例2,将制得的可吸收颅骨,涂上骨生长诱导物质(损伤病人自身骨髓干细胞)植入病人损伤的颅骨内。The preparation method was the same as in Example 2. The prepared absorbable skull was coated with a bone growth inducing substance (injured patient's own bone marrow stem cells) into the skull of the patient's injury.
实施例6Example 6
一种生物可吸收骨修复材料,所述颅骨修复假体的组成成分为生物可吸收聚酯聚合物(聚乙丙交酯(PLGA)20kg、聚乳酸(PLA)20kg、聚L乳酸(PLLA)20kg)60kg与磷酸钙(无定形磷酸钙(ACP)20kg、羟基磷灰石五钙(HAP)20kg)40kg的复合物A bioabsorbable bone repairing material, the composition of the skull repair prosthesis is bioabsorbable polyester polymer (polyethylene glycol (PLGA) 20kg, polylactic acid (PLA) 20kg, poly L lactic acid (PLLA) 20kg) 60kg complex with calcium phosphate (amorphous calcium phosphate (ACP) 20kg, hydroxyapatite pentacalcium (HAP) 20kg) 40kg
制备方法同实施例2,将制得的可吸收颅骨,涂上骨生长诱导物质(成骨因子+药物)植入病人损伤的颅骨内。The preparation method was the same as in Example 2. The prepared absorbable skull was coated with a bone growth inducing substance (osteogenic factor + drug) into the injured skull of the patient.
实施例7Example 7
一种生物可吸收骨修复材料,所述颅骨修复假体的组成成分为生物可吸收聚酯聚合物(聚L乳酸(PLLA)10kg、聚D,L-乳酸(PDLA)20kg、聚乙交酯(PGA)20kg、聚D,L-乙交酯20kg)70kg与磷酸钙(羟基磷灰石五钙(HAP))30kg的复合物。A bioresorbable bone repairing material, the composition of the skull repair prosthesis is bioabsorbable polyester polymer (poly L-lactic acid (PLLA) 10kg, poly D, L-lactic acid (PDLA) 20kg, polyglycolide (PGA) 20kg, poly D, L-glycolide 20kg) 70kg and calcium phosphate (hydroxyapatite pentacalcium (HAP)) 30kg complex.
制备方法同实施例1,将制得的可吸收颅骨涂上骨生长诱导物质(损伤病人自身骨髓干细胞)植入病人损伤的颅骨内。The preparation method is the same as in the first embodiment, and the prepared absorbable skull is coated with a bone growth inducing substance (damaged patient's own bone marrow stem cells) into the skull of the patient's injury.
实施例8Example 8
一种生物可吸收骨修复材料,所述颅骨修复假体的组成成分为生物可吸收聚酯聚合物(聚乙交酯(PGA))80kg与磷酸钙(无定形磷酸钙(ACP)5kg、磷酸二钙(DCP)15kg)20kg的复合物。A bioresorbable bone repairing material, the composition of the skull repair prosthesis is a bioabsorbable polyester polymer (polyglycolide (PGA)) 80 kg and calcium phosphate (amorphous calcium phosphate (ACP) 5 kg, phosphoric acid Dicalcium (DCP) 15kg) 20kg complex.
制备方法同实施例2,将制得的可吸收颅骨,涂上骨生长诱导物质(人工体外培养的成骨干细胞)植入病人损伤的颅骨内。 The preparation method was the same as in Example 2. The prepared absorbable skull was coated with a bone growth inducing substance (osteogenic stem cells cultured in vitro) into the injured skull of the patient.
实施例9Example 9
一种生物可吸收骨修复材料,所述颅骨修复假体的组成成分为生物可吸收聚酯聚合物(聚聚乳酸(PLA)10kg、聚乙交酯(PGA)80kg)90kg与磷酸钙(羟基磷灰石五钙(HAP))10kg的复合物。A bioresorbable bone repairing material, the composition of the skull repair prosthesis is a bioabsorbable polyester polymer (polylactic acid (PLA) 10kg, polyglycolide (PGA) 80kg) 90kg and calcium phosphate (hydroxyl Apatite Pentacalcium (HAP) 10kg complex.
制备方法同实施例2,将制得的可吸收颅骨涂上骨生长诱导物质(损伤病人自身骨髓干细胞)植入病人损伤的颅骨内。The preparation method is the same as in the second embodiment, and the prepared absorbable skull is coated with a bone growth inducing substance (damaged patient's own bone marrow stem cells) into the skull of the patient's injury.
上述实施例,只是本发明的较佳实施例,并非用来限制本发明实施范围,故凡以本发明权利要求所述的特征及原理所做的等效变化或修饰,均应包括在本发明权利要求范围之内。 The above embodiments are merely preferred embodiments of the present invention, and are not intended to limit the scope of the present invention, and equivalent changes or modifications made by the features and principles of the present invention should be included in the present invention. Within the scope of the claims.

Claims (15)

  1. 一种生物可吸收骨修复材料,其特征在于,包括按质量比计算的生物可吸收聚酯聚合物和磷酸钙,所述生物可吸收聚合物与磷酸钙的质量比为1~99∶99~1。A bioabsorbable bone restorative material comprising a bioabsorbable polyester polymer and calcium phosphate calculated by mass ratio, wherein the mass ratio of the bioabsorbable polymer to calcium phosphate is from 1 to 99:99 1.
  2. 如权利要求1所述生物可吸收骨修复材料,其特征在于,所述生物可吸收聚酯聚合物为高分子聚乳酸材料。The bioabsorbable bone repair material according to claim 1, wherein said bioabsorbable polyester polymer is a high molecular polylactic acid material.
  3. 如权利要求2所述生物可吸收骨修复材料,其特征在于,所述高分子聚乳酸材料为聚乙丙交酯、聚乳酸、聚L乳酸、聚D,L-乳酸、聚乙交酯、聚D,L-乙交酯中的一种或几种组合物。The bioabsorbable bone repairing material according to claim 2, wherein the high molecular polylactic acid material is polylactide, polylactic acid, polylactic acid, poly D, L-lactic acid, polyglycolide, One or several compositions of poly D, L-glycolide.
  4. 如权利要求1所述生物可吸收骨修复材料,其特征在于,所述磷酸钙为纳米级别的无定形磷酸钙、磷酸二钙、磷酸三钙、羟基磷灰石五钙、磷酸四钙一氧化碳中的一种或几种组合物。The bioabsorbable bone repairing material according to claim 1, wherein the calcium phosphate is nanometer-sized amorphous calcium phosphate, dicalcium phosphate, tricalcium phosphate, hydroxyapatite pentacalcium, and tetracalcium phosphate carbon monoxide. One or several compositions.
  5. 一种人工假体骨,其特征在于,使用了权利要求1-4中任意一项所述生物可吸收骨修复材料,所述人工假体骨还包括骨生长诱导物质;所述骨生长诱导物质涂覆在所述生物可吸收骨修复材料表面。An artificial prosthetic bone, characterized in that the bioabsorbable bone repair material according to any one of claims 1 to 4, further comprising a bone growth inducing substance; the bone growth inducing substance Coating on the surface of the bioabsorbable bone restorative material.
  6. 如权利要求5述人工假体骨,其特征在于,所述骨生长诱导物质为损伤病人自身骨髓干细胞、人工体外培养的成骨干细胞、成骨因子及药物中的一种或几种组合物。The artificial prosthesis bone according to claim 5, wherein the bone growth inducing substance is one or more of a bone marrow stem cell damaged by the patient, an osteogenic stem cell cultured in vitro, an osteogenic factor, and a drug.
  7. 一种生物可吸收骨修复材料的制备方法,其特征在于,将所述量的生物可吸收聚酯聚合物和磷酸钙通过高速混合器、双螺杆挤出机挤出制得;或将所述 量生物可吸收聚酯聚合物和磷酸钙通过化学方法,纳米微粒悬浮于高分子材料中制得。A method for preparing a bioabsorbable bone repairing material, characterized in that the amount of the bioabsorbable polyester polymer and calcium phosphate are extruded through a high speed mixer or a twin screw extruder; or The bio-absorbable polyester polymer and calcium phosphate are prepared by chemical methods in which the nanoparticles are suspended in a polymer material.
  8. 如权利要求7所述的骨修复材料的制备方法,其特征在于,所述高速混合器内的搅拌速度在1000转/分以上。The method of producing a bone restorative material according to claim 7, wherein the stirring speed in the high speed mixer is 1000 rpm or more.
  9. 如权利要求7所述的骨修复材料的制备方法,其特征在于,所述双螺杆挤出机挤的挤出温度为100~400℃。The method of producing a bone restorative material according to claim 7, wherein the twin-screw extruder has an extrusion temperature of from 100 to 400 °C.
  10. 如权利要求7所述的骨修复材料的制备方法,其特征在于,所述化学方法为改变磷酸钙表面的正负电荷。The method of preparing a bone restorative material according to claim 7, wherein the chemical method is to change the positive and negative charges on the surface of the calcium phosphate.
  11. 如权利要求7所述的骨修复材料的制备方法,其特征在于,所述化学方法为复合材料中添加粘合剂。The method of preparing a bone restorative material according to claim 7, wherein the chemical method adds a binder to the composite material.
  12. 一种人工假体骨的制备方法,其特征在于:将权利要求7-11中任意一项所述生物可吸收骨修复材料制备方法所得到的骨修复材料,再通过注塑法或增材制作法制备而得。A method for preparing artificial prosthesis bone, characterized in that the bone repairing material obtained by the method for preparing the bioabsorbable bone repairing material according to any one of claims 7-11 is further processed by injection molding or additive manufacturing. Prepared.
  13. 如权利要求12所述人工假体骨的制备方法,其特征在于,所述注塑法具体为:先将损伤骨的CT/MRI图像数字化,转化为CAD文件,再在注塑机上,按上述转化的CAD文件,将上述生物可吸收骨修复材料注塑成损伤骨的模型,得到所述人工假体骨。The method for preparing an artificial prosthesis bone according to claim 12, wherein the injection molding method comprises: digitizing a CT/MRI image of the damaged bone into a CAD file, and then converting the same on the injection molding machine. The CAD file is obtained by injection molding the above bioabsorbable bone repair material into a model of damaged bone to obtain the artificial prosthetic bone.
  14. 如权利要求13所述的人工假体骨的制备方法,其特征在于,所述注塑温度100~400℃。 The method of producing artificial prosthesis bone according to claim 13, wherein the injection temperature is 100 to 400 °C.
  15. 如权利要求12所述人工假体骨的制备方法,其特征在于,所述增材料制造法具体为:The method for preparing an artificial prosthesis bone according to claim 12, wherein the method of manufacturing the additive material is specifically:
    A.将损伤骨的CT/MRI影像资料用开源软件转化为STL文件,或其他3D打印机可识别的文件,建立损伤骨之模型;A. Convert the CT/MRI image data of the damaged bone into an STL file using open source software, or a file identifiable by other 3D printers, and establish a model of the damaged bone;
    B.将所述生物可吸收骨修复材料加工成3D打印机可使用的线材;B. processing the bioabsorbable bone repair material into a wire that can be used in a 3D printer;
    C.用融溶烧结法将B中加工成的线材,按A中建立的模型,通过3D打印机逐层烧结叠加成得到所述人工假体骨。 C. Using the melt-sintering method, the wire processed in B is superposed by layer-by-layer sintering according to the model established in A to obtain the artificial prosthetic bone.
PCT/CN2015/087598 2015-06-24 2015-08-20 Bioresorbable bone repair material and application and manufacturing method thereof WO2016206180A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510357178.6 2015-06-24
CN201510357178.6A CN105013006A (en) 2015-06-24 2015-06-24 Bioabsorbable bone repair material and its use and manufacturing method

Publications (1)

Publication Number Publication Date
WO2016206180A1 true WO2016206180A1 (en) 2016-12-29

Family

ID=54403538

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/087598 WO2016206180A1 (en) 2015-06-24 2015-08-20 Bioresorbable bone repair material and application and manufacturing method thereof

Country Status (2)

Country Link
CN (1) CN105013006A (en)
WO (1) WO2016206180A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110559483A (en) * 2018-06-06 2019-12-13 广州溯原生物科技有限公司 Design and application of cancellous bone bionic scaffold prepared by 3d printing technology
CN111330085A (en) * 2020-02-27 2020-06-26 华东理工大学 Traditional Chinese medicine regulation and control type composite active bone scaffold and preparation method and application thereof
CN112704555A (en) * 2021-01-26 2021-04-27 山东建筑大学 Preparation method of degradable porous ulna middle-end fracture connector
CN112773938A (en) * 2019-11-06 2021-05-11 湘潭大学 Strychnine-based 3D printing artificial bone composition and method for preparing strychnine-based 3D printing artificial bone
CN112972773A (en) * 2021-02-04 2021-06-18 深圳先进技术研究院 Bioactive bone composite material and preparation method and application thereof
WO2021175216A1 (en) * 2020-03-02 2021-09-10 华东理工大学 High-strength absorbable composite active internal fixation device and preparation method therefor
US11260592B2 (en) 2016-02-18 2022-03-01 3M Innovative Properties Company 3-D printing surface
WO2023235954A1 (en) * 2022-06-10 2023-12-14 M3 Health Indústria E Comércio De Produtos Médicos, Odontológicos E Correlatos S.A. Medical device based on bioceramics, its use as a synthetic bone graft and process for the preparation thereof

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105268027A (en) * 2015-11-19 2016-01-27 天津市海河医院 Bone tissue engineering stent and preparation method thereof
CN105770996A (en) * 2016-03-11 2016-07-20 金马丁明 Ceramic matrix degradable artificial bone biomaterial for 3D printing
CN105751472B (en) * 2016-04-20 2018-04-24 清华大学深圳研究生院 Biological bone method for manufacturing wire available for FDM 3D printing types
CN105770988B (en) * 2016-04-20 2019-05-14 清华大学深圳研究生院 Bone Defect Repari bioceramic material and preparation method based on 3D printing
CN105944144A (en) * 2016-04-29 2016-09-21 哈尔滨工业大学 Bone tissue repair material based on shape memory composite material as well as preparation method and application method of bone tissue repair structure
CN107721407B (en) * 2016-08-10 2020-09-18 中国科学院上海硅酸盐研究所 Novel bioactive ceramic scaffold based on nutrient element Sr-P-Si and preparation method and application thereof
CN109010923A (en) * 2018-05-04 2018-12-18 宁波诺丁汉新材料研究院有限公司 A kind of 3D printing enhances the preparation method of poly-lactic acid material with phosphate
CN108904881A (en) * 2018-10-11 2018-11-30 泰山医学院 Racemic polylactic acid intersects reinforcement type biodegradability barrier film and preparation method thereof with magnesium net
CN109364304B (en) * 2018-10-16 2021-05-14 南京邦鼎生物科技有限公司 Method for preparing degradable uniform multifunctional biological bionic scaffold through 3D printing
CN109700576A (en) * 2019-01-18 2019-05-03 孟兵 A technique for skull repairing is carried out using stem cell, natural fiber
CN110279898A (en) * 2019-06-06 2019-09-27 中国矿业大学 A kind of novel adsorbable bone class implantation manufacturing method and bone class implant
CN110935064A (en) * 2019-12-11 2020-03-31 深圳薪创生命科技有限公司 3D printing medical prosthesis material and wire production method thereof
CN111110911A (en) * 2020-01-16 2020-05-08 福州大学 High-strength biodegradable 3D printing molded prosthesis prosthetic limb device and preparation method thereof
CN112516384A (en) * 2020-11-03 2021-03-19 南方医科大学深圳医院 Bioactive lumbar fusion cage based on FDM printing and preparation method thereof
CN113117147A (en) * 2021-04-26 2021-07-16 右江民族医学院附属医院 Preparation method of bone tissue repair material and tissue engineering scaffold
CN113456880A (en) * 2021-07-31 2021-10-01 合肥启灏医疗科技有限公司 Biodegradable material and suturing nail
WO2023010909A1 (en) * 2021-07-31 2023-02-09 合肥启灏医疗科技有限公司 Cartilage stabilizer and fully-degradable cartilage stabalization system

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01268560A (en) * 1988-04-20 1989-10-26 Advance Co Ltd Preparation of calcium phosphate ceramics implant
CN1381278A (en) * 2002-05-20 2002-11-27 东南大学 Adsorbable internal fixing material for bone fracture and its preparing process
CN101528158A (en) * 2006-08-21 2009-09-09 21世纪国际新技术株式会社 Bone model, bone filler and process for producing bone filler
CN104147641A (en) * 2014-07-11 2014-11-19 深圳职业技术学院 Bone-repairing material for customizing and preparation method thereof
CN104689373A (en) * 2015-02-05 2015-06-10 广州医科大学附属口腔医院 Bioactive bone repair material containing williams elder twig as well as preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1270783C (en) * 2003-08-08 2006-08-23 浙江大学 Degradable nanometer composite material for biological and medical use
CN102784014B (en) * 2012-08-14 2014-11-26 中国科学院深圳先进技术研究院 Porotic bone scaffold and preparation method thereof
CN103584930B (en) * 2013-10-23 2016-01-06 华南理工大学 A kind of personalized complete knee joint implanting prosthetic reversal design and manufacture method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01268560A (en) * 1988-04-20 1989-10-26 Advance Co Ltd Preparation of calcium phosphate ceramics implant
CN1381278A (en) * 2002-05-20 2002-11-27 东南大学 Adsorbable internal fixing material for bone fracture and its preparing process
CN101528158A (en) * 2006-08-21 2009-09-09 21世纪国际新技术株式会社 Bone model, bone filler and process for producing bone filler
CN104147641A (en) * 2014-07-11 2014-11-19 深圳职业技术学院 Bone-repairing material for customizing and preparation method thereof
CN104689373A (en) * 2015-02-05 2015-06-10 广州医科大学附属口腔医院 Bioactive bone repair material containing williams elder twig as well as preparation method and application thereof

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11260592B2 (en) 2016-02-18 2022-03-01 3M Innovative Properties Company 3-D printing surface
CN110559483A (en) * 2018-06-06 2019-12-13 广州溯原生物科技有限公司 Design and application of cancellous bone bionic scaffold prepared by 3d printing technology
CN112773938A (en) * 2019-11-06 2021-05-11 湘潭大学 Strychnine-based 3D printing artificial bone composition and method for preparing strychnine-based 3D printing artificial bone
CN112773938B (en) * 2019-11-06 2023-03-24 湘潭大学 Strychnine-based 3D printing artificial bone composition and method for preparing strychnine-based 3D printing artificial bone
CN111330085A (en) * 2020-02-27 2020-06-26 华东理工大学 Traditional Chinese medicine regulation and control type composite active bone scaffold and preparation method and application thereof
CN111330085B (en) * 2020-02-27 2024-02-13 华东理工大学 Traditional Chinese medicine regulation type composite active bone scaffold and preparation method and application thereof
WO2021175216A1 (en) * 2020-03-02 2021-09-10 华东理工大学 High-strength absorbable composite active internal fixation device and preparation method therefor
CN112704555A (en) * 2021-01-26 2021-04-27 山东建筑大学 Preparation method of degradable porous ulna middle-end fracture connector
CN112972773A (en) * 2021-02-04 2021-06-18 深圳先进技术研究院 Bioactive bone composite material and preparation method and application thereof
CN112972773B (en) * 2021-02-04 2022-03-08 深圳先进技术研究院 Bioactive bone composite material and preparation method and application thereof
WO2022166408A1 (en) * 2021-02-04 2022-08-11 深圳先进技术研究院 Bioactive composite material for bone and preparation method therefor and use thereof
WO2023235954A1 (en) * 2022-06-10 2023-12-14 M3 Health Indústria E Comércio De Produtos Médicos, Odontológicos E Correlatos S.A. Medical device based on bioceramics, its use as a synthetic bone graft and process for the preparation thereof

Also Published As

Publication number Publication date
CN105013006A (en) 2015-11-04

Similar Documents

Publication Publication Date Title
WO2016206180A1 (en) Bioresorbable bone repair material and application and manufacturing method thereof
Feng et al. Application of 3D printing technology in bone tissue engineering: a review
Harris et al. History of synthetic materials in alloplastic cranioplasty
Smith et al. Computed tomography‐based tissue‐engineered scaffolds in craniomaxillofacial surgery
da Silva et al. A comprehensive review on additive manufacturing of medical devices
Wurm et al. Prospective study on cranioplasty with individual carbon fiber reinforced polymere (CFRP) implants produced by means of stereolithography
Peng et al. Rapid prototyping-assisted maxillofacial reconstruction
Baino et al. Bioceramics in ophthalmology
Kim Application of the three-dimensionally printed biodegradable polycaprolactone (PCL) mesh in repair of orbital wall fractures
Kanno et al. Computed tomographic evaluation of novel custom-made artificial bones,“CT-bone”, applied for maxillofacial reconstruction
CN114504677B (en) 3D printing skull repairing titanium mesh and preparation method thereof
Grecchi et al. Reconstruction of the zygomatic bone with smartbone®: Case report
Shi et al. Customized barrier membrane (titanium alloy, poly ether-ether ketone and Unsintered hydroxyapatite/poly-l-Lactide) for guided bone regeneration
Augustin et al. Comparison of two pore sizes of LAE442 scaffolds and their effect on degradation and osseointegration behavior in the rabbit model
Mekala et al. Review on engineering biomaterials in tissue engineering application
CN108283732B (en) Bone grafting composite material for alveolar bone increment
Hao et al. Customised implants for bone replacement and growth
CN213525691U (en) Simulation jaw bone implant based on 3D printing of porous titanium alloy
CN112842623A (en) Method for modifying surface of hydroxyapatite by 3D (three-dimensional) bioprinting degradable artificial rib
Hudecki et al. Orbital reconstruction-applied materials, therapeutic agents and clinical problems of restoration of defects
Asano et al. Preparation of thermoplastic poly (L-lactic acid) membranes for guided bone regeneration.
RU25996U1 (en) IMPLANT FOR CONTOUR PLASTIC, RESTORATION, CORRECTION, ELIMINATION OR REPLACEMENT OF DEFECTS, DAMAGES OR DEFORMATIONS OF BONE OR CARTILAGE TISSUE
Hatton et al. Medical applications of 3D Printing
Han et al. Injectable bioactive glass in the restoration of oral bone defect.
Cheng et al. 3D printed biomaterials for maxillofacial tissue engineering and reconstruction—a review

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15896075

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15896075

Country of ref document: EP

Kind code of ref document: A1